Yuebing Li, MD, PhD

Appointed
2012

Education & Fellowships

Fellowship - University of Cincinnati Medical Center/University Hospital
Clinical Neurophysiology
Cincinnati, OH USA
2003

Residency - University of Cincinnati Medical Center/University Hospital
Neurology
Cincinnati, OH USA
2002

Internship - The Christ Hospital
Medicine
Cincinnati, OH USA
1999

Medical Education - University of Pennsylvania School of Medicine
Philadelphia, PA USA
1998

Medical Education - Qingdao Medical College
Shandong,
1986

Professional Highlights

• Selected publications:
  1. Claytor B, Li Y. Challenges in diagnosing coexisting ocular myasthenia gravis and thyroid eye disease. Accepted by Muscle Nerve.
  2. Amin M, Purohit M, Calabrese C, Prayson R, Li Y. Hypertrophic pachymeningitis and choroid plexitis in IgG-4 related disease. Accepted by Neurology: Clinical Practice.
  3. Barohn RJ, Gajewski B, Pasnoor M, Brown A, Herbelin LL, Kimminau KS, Mudaranthakam DP et al. Patient assisted intervention for neuropathy: Comparison of treatment in real life situations (PAIN-CONTRoLS): Bayesian adaptive comparative effectiveness randomized trial. Accepted by JAMA Neurol.
  4. Pike-lee T, Syed S, Willis M. Li, Y. Pneumocystis jirovecii pneumonia in neurological disorders: is prophylaxis necessary? Accepted by Neurology: Clinical Practice.
  5. Pike-Lee T, Hill J, Li J, Kosmorsky G. Li Y. Comitant ocular deviation in myasthenia gravis. Accepted by Journal of Neuro-ophthalmology.
  6. Morren J, Li Y. Maintenance immunosuppression in myasthenia gravis, an update. Accepted by Journal of the Neurological Sciences.
  7. Pike-Lee T, Li Y. Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated With Rare Autoimmune Conditions. RRNMF Clinical Neuromuscular Journal. 2020; 1(5): 13-16.
  8. Li Y, Thakore N. An appraisal of electrodiagnostic studies in stiff person syndrome. Journal of Clinical Neuromuscular Disease. 2020; 22(2): 84-89.
  9. Hehir M, Li Y. Rituximab for Late Onset MG: Evidence Mounting but Deliberations Continue.  Muscle Nerve. 2020; 62(3): 297-299.
  10. Pike-Lee T, Li Y, Wolfe G. Neuromuscular Complications in COVID-19: A Review of the Literature. RRNMF Clinical Neuromuscular Journal. 2020; 1(3): 13-21.
  11. Dengler R, de Carvalho M, Shahrizaila N, Nodera H, Vucic S, Grimm A, Padua L, Schreiber S, Kneiser MK, Hobson-Webb LD, Boon AJ, Smith BE, Litchy WJ, Li Y, Lenihan M, Thompson VB, Stalberg E, Sanders DB, Kincaid JC.  AANEM - IFCN Glossary of Terms in Neuromuscular Electrodiagnostic Medicine and Ultrasound. Clinical Neurophysiology. 2020;131(7):1662-1663.
  12. Dengler R, de Carvalho M, Shahrizaila N, Nodera H, Vucic S, Grimm A, Padua L, Schreiber S, Kneiser MK, Hobson-Webb LD, Boon AJ, Smith BE, Litchy WJ, Li Y, Lenihan M, Thompson VB, Stalberg E, Sanders DB, Kincaid JC. AANEM - IFCN Glossary of Terms in Neuromuscular Electrodiagnostic Medicine and Ultrasound. Muscle Nerve. 2020;62(1):10-12.
  13. Lee T, Twydell P, Li Y. Anterior Spinal Extradural Cyst Mimicking Hirayama Disease and Amyotrophic Lateral Sclerosis. RRNMF Clinical Neuromuscular Journal. 2020; 1(1); 47-49.
  14. Hill J, Karwa K, Li Y. Peripheral nerve hyperexcitability following titanium marker placement. RRNMF Clinical Neuromuscular Journal. 2020; 1(1): 45-46.
  15. Ritch M, Suhaib O, Li Y. Sciatic neuropathy with preserved sensory nerve action potentials, a case series. RRNMF Clinical Neuromuscular Journal. 2020; 1(1): 26-30.
  16. Parikh P, Polston D, Li Y. Prevalence of denervation in the intrinsic foot muscles in patients with distal predominantly small fiber neuropathy. Muscle Nerve.2020; 61(5): 595-599. 
  17. Feldman L, Li Y and Ontaneda D. Primary Central Nervous System Lymphoma Initially Diagnosed as Vasculitis. Neurology: Clinical Practice. 2020; 10(1): 84-88.
  18. Lee T, Li Y. Consideration of repetitive nerve stimulation of the median nerve in patients being evaluated for myasthenia gravis, Muscle Nerve. 2019;60(6):658-661.
  19. MacDonald S, Sharma T, Li J, Polston D, Li Y. Longitudinal follow-up of biopsy-proven small fiber neuropathy. Muscle Nerve. 2019;60(4):376-381.
  20. Pike-Lee T, Li Y. Letter to the editors in regard to the article "Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis". Journal of the Neurological Sciences. 2019;405:116403.
  21. Marquardt R, Li Y. Congenital Myasthenic Syndrome Type 19 due to a novel mutation in the COL13A1 gene. Muscle Nerve. 2019;60(1):E3-E4.
  22. Shouman K, Li Y. Reversible Conduction Failure in Chronic Immune-mediated Sensorimotor and Autonomic Polyneuropathy. Journal of Clinical Neuromuscular Disease.2019; 20 (4):200-206.
  23. Feldman L. Li Y. Neurologic manifestation associated with cryoglobulinemia: a single center experience. Journal of the Neurological Sciences. 2019;398:121-127.
  24. Thammongkolchai T, Suhaib O, Termsarasab P, Li Y, Katirji B. Chronic Immune Sensorimotor Polyradiculopathy (CISMP): Report of a Case Series. Muscle Nerve. 2019;59(6):658-664.
  25. Kushlaf H. Li Y. The evidence is stacked against thymectomy in MuSK myasthenia gravis. Muscle Nerve. 2019; 59: 393-394.
  26. Cherian R, Li Y. Clinical and electrodiagnostic features of non-traumatic sciatic neuropathy.  Muscle Nerve. 2019; 59: 309-314. 
  27. Di Lorenzo R, Mente K, Li J, Shayya L, Rae-Grant A, Li Y, Jammoul A. Low specificity of voltage-gated calcium channel antibodies in Lambert-Eaton myasthenic syndrome: A call for caution. Journal of Neurology. 2018; 265: 2114-2119.
  28. Shayya L, Babu S, Pioro EK and Li Y. Distal predominance of lower motor neuron degeneration on the electromyographic study of early-stage amyotrophic lateral sclerosis. Muscle Nerve.2018;58(3):389-395. 
  29. Morren J, Li Y. Myasthenia Gravis with Muscle-Specific Tyrosine Kinase (MuSK) Antibodies- A Narrative Review. Muscle Nerve. 2018;58(3):344-358.
  30. Marquardt R, Li Y. Lumbosacral Radiculoplexopathy as the Initial Presentation of Lymphoma: A Report of Four Cases. Journal of Clinical Neuromuscular Disease. 2018;19(4):196-202.
  31. Parikh P, Tavee J, Mammen AL, McKeever P, Li Y. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibody-positive necrotizing autoimmune myopathy with dermatomyositis-like eruption. Muscle Nerve. 2018;57(6):E135-E136.
  32. Hu B, McCollum M, Ravi V, Arpag S, Moiseev D, Castoro R, Mobley B, Burnette B, Siskind C, Day J, Yawn R, Feely S, Li Y, Yan Q, Shy M, Li J. Myelin Abnormality in CMT4J Recapitulates Features of Acquired Demyelination. Annals of Neurology. 2018;83(4):756-770.
  33. Guber RD, Schindler AB, Budron MS, Chen KL, Li Y, Fischbeck KH, Grunseich G. Nucleocytoplasmic transport defect in a North American patient with ALS8. Annals of Clinical and Translational Neurology. 2018;5(3):369-375.
  34. Li Y. Axonal sensorimotor polyneuropathies. Continuum. 2017; 23(5): 1378-1393.
  35. Castaldo J, Yacoub H, Li Y, Kincaid H. Jenny D. Open Heart Surgery Does Not Increase the Incidence of Ipsilateral Ischemic Stroke in Patients with Asymptomatic Severe Carotid Stenosis. Journal of Stroke and Cerebrovascular Diseases.2017; 26(10): 2154-2159.
  36. Sharma T, Yeaney G, Soltanzadeh P, Li Y, Cotta C, Intravascular T-Cell Lymphoma:  A rare, poorly characterized entity with cytotoxic phenotype. Neuropathology. 2017; 37: 365-370.
  37. Li Y, Valent J, Soltanzadeh P,  Thakore N,  Katirji B. Diagnostic challenges in POEMS Syndrome Presenting with Polyneuropathy: a case series. Journal of the Neurological Sciences. 2017; 378: 170-174.
  38. Lorenzo DR. Li Y. Rhabdomyolysis Associated with Levetiracetam Administration. Muscle Nerve. 2017; 56(1): E1-E2
  39. Babu S, Pioro E, Li J, Li Y. Optimizing muscle selection for electromyography in amyotrophic lateral sclerosis.  Muscle Nerve. 2017; 56(1): 36-44.
  40. Adham J, Shayya L, Mente K, Li J, Rae-Grant A, Li Y. Clinical utility of seropositive voltage gated potassium channel (VGKC) complex antibody. Neurology: Clinical Practice.2016; 6: 409-418.
  41. Gotterer L, Li Y. Maintenance immunosuppression in myasthenia gravis. Journal of the Neurological Sciences. 2016; 369: 294-302.
  42. Zhu J, Li Y. Myasthenia gravis exacerbation associated with pembrolizumab. Muscle Nerve. 2016; 54(3): 506-507.
  43. Donaldson R, Li J, Li Y. Clinical significance of cation channel antibodies in motor neuron disease. Muscle Nerve. 2016; 54(2):228-231.
  44. Burns TM, Smith GA, Allen JA, Amato AA, Arnold WD, Barohn R et al.  Editorial by concerned physicians: Unintended effect of the Orphan Drug Act on the potential cost of 3,4-diaminopyridine. Muscle Nerve. 2016; 53(2):165-168.
  45. Jammoul A, Li Y, Rae-Grant A. Autoantibody-mediated encephalitis: not just paraneoplastic, not just limbic, and not untreatable.  Cleveland Clinic Journal of Medicine.  2016; 83(1):43-53.
  46. AANEM glossary of terms in neuromuscular & electrodiagnostic medicine. Muscle Nerve. 2015; 52 Suppl 3:145-203.
  47. Sheikhi L, Li Y, Jimenez XF. A case of familial frontotemporal dementia presenting with malignant catatonia. Neurology: Clinical Practice. 2015; 5(6): 521-523.
  48. Li Y, Jammoul A, Mente K, Li J, Shields RW, Vernino S, Rae-Grant A. Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center. Muscle Nerve. 2015; 52(3): 386-391. 
  49. Wang L, Li Y. Longitudinal ultra-extensive transverse myelitis as a manifestation of neurosarcoidosis. Journal of the Neurological Sciences.2015; 355: 64-67.
  50. Babu S, Li Y. Statin induced necrotizing autoimmune myopathy. Journal of Neurological Sciences. 2015; 351(1-2):13-17.
  51. Santos –Pinheiro F. Li Y. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) presenting with polyneuropathy - a case series. Journal of Clinical Neuromuscular Disease. 2015; 16(3): 125-130.
  52. Wang L, Holthaus EA, Jimenez XF,  Tavee J, Li Y. MRI  evolution of CLIPPERS  syndrome  following  herpes  zoster infection. Journal of Neurological Sciences. 2015, 348(1-2):277-278.
  53. Jammoul A, Lederman RJ, Tavee J, Li Y. Presence of voltage-gated potassium channel complex antibody in a case of genetic prion disease. BMJ Case Reports. 2014; pii: bcr2013201622.
  54. Li Y, Lederman RJ.  Sural mononeuropathy: A report of 36 cases. Muscle Nerve. 2014; 49(3):443-445.
  55. Li Y., Castaldo J., Bemporad J., Yacoub H.A. Reversible confluent periventricular white matter abnormalities, a new variant of posterior reversible encephalopathy syndrome, Case Reports in Neurological Medicine. 2013, Article ID 536978.
  56. Li Y, Arora Y, Levin K. Myasthenia gravis: new therapies offer sustained improvement. Cleveland Clinic Journal of Medicine. 2013; 80(11):711-721.
  57. Arora Y, Li Y. Overview of myasthenia gravis. Hospital Practice.  2013; 41(4):40-50.
  58. Kumar H, Li Y. Teaching neuroimages: Sciatic neuropathy after heroin abuse. Neurology 2013; 81: e51. 
  59. Li L, Shaff D, Li Y. De novo dural arteriovenous fistula formation following asymptomatic sinus thrombosis: a case report and review of the literature. Journal of Neurology Research 2013; 3(2): 73-77.
  60. Li Y, Remmel K. Relapsing polyradiculoneuropathy as a neurological manifestation of systemic lupus erythematosus. Muscle and Nerve 2012, 46(5): 828-829.
  61. Li, Y, Gor D, Walicki D, Jenny D, Jones D, Barbour P, Castaldo J. The spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome. Journal of Stroke and Cerebrovascular Diseases 2012, 21(8): 873-882.
  62. Li Y, Isayev Y, Li Y. Spinal hemorrhage leading to cerebral vasospasm and infarction. Journal of Neurology Research 2012; 2(4): 164-167.
  63. Li Y, Remmel K. A case of monomelic amyotrophy of the upper limb: MRI findings and the implication on its pathogenesis.  Journal of Clinical Neuromuscular Diseases 2012; 13(4): 234-239.
  64. Li Y, Jenny D, Castaldo J. Posterior reversible encephalopathy syndrome: Clinicoradiological spectrum, early recognition and therapeutic strategies. Hospital Practice 2012; 40 (1): 202-213.
  65. Li Y, Margraf J, Kluck B, Jenny D, Castaldo J. Thrombolytic therapy for ischemic stroke secondary to paradoxical embolism in pregnancy, a case report and literature review. Neurologist 2012; 18(1):44-48.
  66. Nwoke F. and Li, Y. Focal thalamic and cortical magnetic response changes associated with partial status epilepticus. Journal of Neurology Research 2011; 1(4):170-174.
  67. Li Y, Castaldo J, Van der Hetden J, Plokker H.  Is carotid artery disease responsible for perioperative strokes after coronary artery bypass surgery? Journal of Vascular Surgery 2010; 52: 1716-1721.
  68. Li Y, Castaldo J. Carotid disease is rarely responsible for stroke after coronary bypass surgery. European Journal of Vascular Endovascular Surgery 2010; 40: 689-693
  69. Li Y, Jenny D, Castaldo J. Cardiac surgery, carotid stenosis and stroke prevention. Hospital Practice 2010; 38: 29-39.
  70. Li Y, Jenny D, Bemporad J., Castaldo J. Sulcal artery syndrome following vertebral artery dissection. Journal of Stroke and Cerebrovascular Diseases 2010; 19: 333-335.
  71. Li Y, Clauser D, Jenny D, Castaldo J. Falsely disappearing stroke secondary to isodense subdural hematoma. Neurology 2010; 74: e15.
  72. Li Y, Walicki D, Mathiesen C, Jenny D, Li Q, Isayev Y, Reed J, Castaldo J. Strokes following open heart surgery and carotid artery stenosis. Archives of Neurology 2009; 66(9): 1091-1096.

Certifications

• Electrodiagnostic Medicine
• Psychiatry and Neurology - Neurology

Specialty Interests

Autoimmune Polyneuropathy Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Dermatomyositis Inclusion Body Myositis (IBM) Inherited Neuropathies Muscular Dystrophy Myasthenia Gravis Myopathy Plexopathy Polymyositis

Memberships

• Member, American Academy of Neurology
• Member, American Academy of Neuromuscular and  Electrodiagnostic Medicine

See publications for Yuebing Li, MD, PhD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/3/2023, Dr. Li has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Li receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Argenx

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.